BETHLEHEM, Pa.--(BUSINESS WIRE)--Saladax Biomedical, Inc. (Saladax) is pleased to announce the approval of five MyCare™…
adminFebruary 17, 2021
Saladax Biomedical launches clozapine test in the US after FDA grants market authorization Saladax is…
adminJuly 8, 2020
The MyCare Insite is a point-of-care (POC) device that uses just a single drop of…
adminJune 27, 2020
Fully automated immunoassay kit designed to simplify and streamline busulfan therapeutic drug monitoring (TDM), potentially…
adminMay 4, 2020
Saladax is advancing personalized medicine by providing psychiatrists with the first commercially available antipsychotic test…
adminMay 1, 2020
View the original press release at businesswire.com Bethlehem, PA – October 24, 2019 –Saladax Biomedical,…
adminOctober 24, 2019
adminOctober 18, 2019
Bethlehem, PA – September 05, 2019 –Saladax Biomedical today announced that its MyCare Insite Clozapine Test…
adminSeptember 5, 2019
Bethlehem, PA – September 19, 2018 – Saladax Biomedical Inc., a diagnostics company providing kits…
adminSeptember 19, 2018
